Jun 22, 2021 / 12:40PM GMT
Timor Ivannikov - Raymond James Financial - Analyst
Hello, everyone. My name is Timor Ivannikov, and I am a biotech analyst at Raymond James. Today, we are pleased to host Agenus at our annual Human Health Innovation Conference. Presenting on behalf of Agenus, we welcome President and COO, Jennifer Buell; and we also have Director of IR, Jan Medina. Agenus is a clinical-stage immuno-oncology biotech company. (Conference Instructions). So thank you, everyone, for joining us today. And please go ahead, Jennifer.
Jennifer Buell - Agenus Inc. - President & COO
Timor, thanks very much for the opportunity to be here. I appreciate it. And thank you to the Raymond James group. We are really pleased to present Agenus. I'm going to go ahead and just share a couple of slides, and I'll tell you -- I'm going to focus really on a couple of core points about Agenus -- what we are doing, who we are, and where we are going. Can you see my screen okay, Timor?
Timor Ivannikov - Raymond James Financial - Analyst
Yes, yes, we see it.
Agenus Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers